These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 31654704)

  • 1. Selective inhibition of mTORC1/2 or PI3K/mTORC1/2 signaling does not prevent or modify epilepsy in the intrahippocampal kainate mouse model.
    Gericke B; Brandt C; Theilmann W; Welzel L; Schidlitzki A; Twele F; Kaczmarek E; Anjum M; Hillmann P; Löscher W
    Neuropharmacology; 2020 Jan; 162():107817. PubMed ID: 31654704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The novel, catalytic mTORC1/2 inhibitor PQR620 and the PI3K/mTORC1/2 inhibitor PQR530 effectively cross the blood-brain barrier and increase seizure threshold in a mouse model of chronic epilepsy.
    Brandt C; Hillmann P; Noack A; Römermann K; Öhler LA; Rageot D; Beaufils F; Melone A; Sele AM; Wymann MP; Fabbro D; Löscher W
    Neuropharmacology; 2018 Sep; 140():107-120. PubMed ID: 30081001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain-penetrant PQR620 mTOR and PQR530 PI3K/mTOR inhibitor reduce huntingtin levels in cell models of HD.
    Singer E; Walter C; Fabbro D; Rageot D; Beaufils F; Wymann MP; Rischert N; Riess O; Hillmann P; Nguyen HP
    Neuropharmacology; 2020 Jan; 162():107812. PubMed ID: 31622602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel brain permeant mTORC1/2 inhibitors are as efficacious as rapamycin or everolimus in mouse models of acquired partial epilepsy and tuberous sclerosis complex.
    Theilmann W; Gericke B; Schidlitzki A; Muneeb Anjum SM; Borsdorf S; Harries T; Roberds SL; Aguiar DJ; Brunner D; Leiser SC; Song D; Fabbro D; Hillmann P; Wymann MP; Löscher W
    Neuropharmacology; 2020 Dec; 180():108297. PubMed ID: 32890589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery and Preclinical Characterization of 5-[4,6-Bis({3-oxa-8-azabicyclo[3.2.1]octan-8-yl})-1,3,5-triazin-2-yl]-4-(difluoromethyl)pyridin-2-amine (PQR620), a Highly Potent and Selective mTORC1/2 Inhibitor for Cancer and Neurological Disorders.
    Rageot D; Bohnacker T; Melone A; Langlois JB; Borsari C; Hillmann P; Sele AM; Beaufils F; Zvelebil M; Hebeisen P; Löscher W; Burke J; Fabbro D; Wymann MP
    J Med Chem; 2018 Nov; 61(22):10084-10105. PubMed ID: 30359003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Various modifications of the intrahippocampal kainate model of mesial temporal lobe epilepsy in rats fail to resolve the marked rat-to-mouse differences in type and frequency of spontaneous seizures in this model.
    Klee R; Brandt C; Töllner K; Löscher W
    Epilepsy Behav; 2017 Mar; 68():129-140. PubMed ID: 28167446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mammalian target of rapamycin signaling pathway mediates epileptogenesis in a model of temporal lobe epilepsy.
    Zeng LH; Rensing NR; Wong M
    J Neurosci; 2009 May; 29(21):6964-72. PubMed ID: 19474323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significant effects of sex, strain, and anesthesia in the intrahippocampal kainate mouse model of mesial temporal lobe epilepsy.
    Twele F; Töllner K; Brandt C; Löscher W
    Epilepsy Behav; 2016 Feb; 55():47-56. PubMed ID: 26736063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Canonical Wnt activator Chir99021 prevents epileptogenesis in the intrahippocampal kainate mouse model of temporal lobe epilepsy.
    Mardones MD; Rostam KD; Nickerson MC; Gupta K
    Exp Neurol; 2024 Jun; 376():114767. PubMed ID: 38522659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioral alterations in a mouse model of temporal lobe epilepsy induced by intrahippocampal injection of kainate.
    Gröticke I; Hoffmann K; Löscher W
    Exp Neurol; 2008 Sep; 213(1):71-83. PubMed ID: 18585709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the Mouse Ventral Hippocampus in the Intrahippocampal Kainic Acid Model of Temporal Lobe Epilepsy.
    Zeidler Z; Brandt-Fontaine M; Leintz C; Krook-Magnuson C; Netoff T; Krook-Magnuson E
    eNeuro; 2018; 5(4):. PubMed ID: 30131968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent seizures and hippocampal sclerosis following intrahippocampal kainate injection in adult mice: electroencephalography, histopathology and synaptic reorganization similar to mesial temporal lobe epilepsy.
    Bouilleret V; Ridoux V; Depaulis A; Marescaux C; Nehlig A; Le Gal La Salle G
    Neuroscience; 1999 Mar; 89(3):717-29. PubMed ID: 10199607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The intrahippocampal kainate model of temporal lobe epilepsy revisited: epileptogenesis, behavioral and cognitive alterations, pharmacological response, and hippoccampal damage in epileptic rats.
    Rattka M; Brandt C; Löscher W
    Epilepsy Res; 2013 Feb; 103(2-3):135-52. PubMed ID: 23196211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A guinea pig model of mesial temporal lobe epilepsy following nonconvulsive status epilepticus induced by unilateral intrahippocampal injection of kainic acid.
    Carriero G; Arcieri S; Cattalini A; Corsi L; Gnatkovsky V; de Curtis M
    Epilepsia; 2012 Nov; 53(11):1917-27. PubMed ID: 22998690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A face-to-face comparison of the intra-amygdala and intrahippocampal kainate mouse models of mesial temporal lobe epilepsy and their utility for testing novel therapies.
    Welzel L; Schidlitzki A; Twele F; Anjum M; Löscher W
    Epilepsia; 2020 Jan; 61(1):157-170. PubMed ID: 31828786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Agomelatine protects against neuronal damage without preventing epileptogenesis in the kainate model of temporal lobe epilepsy.
    Tchekalarova J; Atanasova D; Nenchovska Z; Atanasova M; Kortenska L; Gesheva R; Lazarov N
    Neurobiol Dis; 2017 Aug; 104():1-14. PubMed ID: 28438504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naringin attenuates granule cell dispersion in the dentate gyrus in a mouse model of temporal lobe epilepsy.
    Jang H; Jeong KH; Kim SR
    Epilepsy Res; 2016 Jul; 123():6-10. PubMed ID: 27040812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The AMPA receptor antagonist NBQX exerts anti-seizure but not antiepileptogenic effects in the intrahippocampal kainate mouse model of mesial temporal lobe epilepsy.
    Twele F; Bankstahl M; Klein S; Römermann K; Löscher W
    Neuropharmacology; 2015 Aug; 95():234-42. PubMed ID: 25839899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repeated low-dose kainate administration in C57BL/6J mice produces temporal lobe epilepsy pathology but infrequent spontaneous seizures.
    Umpierre AD; Bennett IV; Nebeker LD; Newell TG; Tian BB; Thomson KE; White HS; White JA; Wilcox KS
    Exp Neurol; 2016 May; 279():116-126. PubMed ID: 26896834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naringenin ameliorates kainic acid-induced morphological alterations in the dentate gyrus in a mouse model of temporal lobe epilepsy.
    Park J; Jeong KH; Shin WH; Bae YS; Jung UJ; Kim SR
    Neuroreport; 2016 Oct; 27(15):1182-9. PubMed ID: 27584687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.